{"meshTags":["Aged","Female","Middle Aged","Male","Humans","Carcinoma, Squamous Cell","Esophageal Neoplasms","Uracil","Tegafur","Antineoplastic Combined Chemotherapy Protocols"],"meshMinor":["Aged","Female","Middle Aged","Male","Humans","Carcinoma, Squamous Cell","Esophageal Neoplasms","Uracil","Tegafur","Antineoplastic Combined Chemotherapy Protocols"],"organisms":["9606"],"publicationTypes":["Case Reports","English Abstract","Journal Article"],"abstract":"We report two patients with esophageal cancer who responded to UFT. The patients were a 71-year-old female and a 61-year-old male, both of whom had recurrent disease in the esophagus or abdominal lymph nodes. They had received previous treatment consisting of radiotherapy and chemotherapy containing cisplatin, methotrexate and peplomycin. Each patient was administered UFT 400 mg/day p.o. No toxic effect was seen.","title":"[UFT in esophageal cancer: a report of two cases].","pubmedId":"3118816"}